Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 2
2008 2
2011 1
2012 3
2013 2
2014 1
2015 6
2016 5
2017 6
2018 7
2019 6
2020 11
2021 11
2022 8
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for qiu feng mo
Search for Qiufeng Mo instead (2 results)
Association of Beta-Blocker Therapy With Cardiovascular Outcomes in Patients With Stable Ischemic Heart Disease.
Godoy LC, Farkouh ME, Austin PC, Shah BR, Qiu F, Jackevicius CA, Wijeysundera HC, Krumholz HM, Ko DT. Godoy LC, et al. Among authors: qiu f. J Am Coll Cardiol. 2023 Jun 20;81(24):2299-2311. doi: 10.1016/j.jacc.2023.04.021. J Am Coll Cardiol. 2023. PMID: 37316110
Beta-blocker use was defined as having at least 1 beta-blocker prescription claim in the 90 days preceding or after the index coronary angiography. The main outcome was a composite of all-cause mortality and hospitalization for heart failure or myocardial infarction. ...
Beta-blocker use was defined as having at least 1 beta-blocker prescription claim in the 90 days preceding or after the index coronary angio …
Differences in Treatment Patterns and Outcomes of Acute Myocardial Infarction for Low- and High-Income Patients in 6 Countries.
Landon BE, Hatfield LA, Bakx P, Banerjee A, Chen YC, Fu C, Gordon M, Heine R, Huang N, Ko DT, Lix LM, Novack V, Pasea L, Qiu F, Stukel TA, Uyl-de Groot C, Yan L, Weinreb G, Cram P. Landon BE, et al. Among authors: qiu f. JAMA. 2023 Apr 4;329(13):1088-1097. doi: 10.1001/jama.2023.1699. JAMA. 2023. PMID: 37014339 Free PMC article.
For instance, 30-day mortality among patients admitted with STEMI in the Netherlands was 10.2% for those with high income vs 13.1% for those with low income (difference, -2.8 percentage points [95% CI, -4.1 to -1.5]). One-year mortality differences for STEMI were ev …
For instance, 30-day mortality among patients admitted with STEMI in the Netherlands was 10.2% for those with high income vs 13.1% fo …
Prognostic value of inflammation biomarkers for 30-day mortality in critically ill patients with stroke.
Zhao J, Feng J, Ma Q, Li C, Qiu F. Zhao J, et al. Among authors: qiu f. Front Neurol. 2023 Feb 6;14:1110347. doi: 10.3389/fneur.2023.1110347. eCollection 2023. Front Neurol. 2023. PMID: 36814998 Free PMC article.
The increased NAR level was associated with elevated risk of 30-day mortality in hemorrhagic stroke (HR = 1.16, 95% CI: 1.02-1.30). The high RA level was linked with increased risk of 30-day mortality (HR = 1.44, 95% CI: 1.23-1.69). ...CONCLUSION: NLR, NAR, and RA w …
The increased NAR level was associated with elevated risk of 30-day mortality in hemorrhagic stroke (HR = 1.16, 95% CI: 1.02-1.30). T …
Outcomes Among Patients Hospitalized With Non-COVID-19 Conditions Before and During the COVID-19 Pandemic in Alberta and Ontario, Canada.
McAlister FA, Chu A, Qiu F, Dong Y, van Diepen S, Youngson E, Yu AYX, de Mestral C, Ross HJ, Austin PC, Lee DS, Kadri SS, Wijeysundera HC; CORONA Collaboration. McAlister FA, et al. Among authors: qiu f. JAMA Netw Open. 2023 Jul 3;6(7):e2323035. doi: 10.1001/jamanetworkopen.2023.23035. JAMA Netw Open. 2023. PMID: 37436751 Free PMC article.
Once capacity reached above the 99th percentile, patients' 30-day mortality AOR was 1.80 (95% CI, 1.24-2.61) vs when the surge index was below the 75th percentile. CONCLUSIONS AND RELEVANCE: This cohort study found that during surges in COVID-19 caseloads, mortality …
Once capacity reached above the 99th percentile, patients' 30-day mortality AOR was 1.80 (95% CI, 1.24-2.61) vs when the surge index …
Surveillance Imaging Following Acute Type A Aortic Dissection.
An KR, de Mestral C, Tam DY, Qiu F, Ouzounian M, Lindsay TF, Wijeysundera HC, Chung JC. An KR, et al. Among authors: qiu f. J Am Coll Cardiol. 2021 Nov 9;78(19):1863-1871. doi: 10.1016/j.jacc.2021.08.058. Epub 2021 Oct 22. J Am Coll Cardiol. 2021. PMID: 34696957 Free article.
A total of 14% patients received GDIS throughout follow-up. At 6 years, 3.9% of patients had received GDIS. The mortality rate was 4% at 1 year, 14% at 5 years, and 29% at 10 years. Incidence of aortic reintervention was 3% at 1 year, 9% at 5 years, and 17% at 10 years; th …
A total of 14% patients received GDIS throughout follow-up. At 6 years, 3.9% of patients had received GDIS. The mortality rate was 4% …
Clinical evidence of an interferon-glucocorticoid therapeutic synergy in COVID-19.
Lu Y, Liu F, Tong G, Qiu F, Song P, Wang X, Zou X, Wan D, Cui M, Xu Y, Zheng Z, Hong P. Lu Y, et al. Among authors: qiu f. Signal Transduct Target Ther. 2021 Mar 3;6(1):107. doi: 10.1038/s41392-021-00496-5. Signal Transduct Target Ther. 2021. PMID: 33658482 Free PMC article.
Synthetic glucocorticoid dexamethasone is the first trial-proven drug that reduces COVID-19 mortality by suppressing immune system. In contrast, interferons are a crucial component of host antiviral immunity and can be directly suppressed by glucocorticoids. ...
Synthetic glucocorticoid dexamethasone is the first trial-proven drug that reduces COVID-19 mortality by suppressing immune system. I …
Flavonoids from Eucommia ulmoides and their in vitro hepatoprotective activities.
Huang W, Ding L, Zhang N, Li W, Koike K, Qiu F. Huang W, et al. Among authors: qiu f. Nat Prod Res. 2021 Nov;35(21):3584-3591. doi: 10.1080/14786419.2020.1715402. Epub 2020 Jan 28. Nat Prod Res. 2021. PMID: 31992074
The new compound, eucommiaflavone (1) was structurally elucidated by various spectroscopic analyses. In particular, Mo(2)(OAc)(4)-induced circular dichroism (ICD) analysis was applied to determine the absolute configuration of 1. ...
The new compound, eucommiaflavone (1) was structurally elucidated by various spectroscopic analyses. In particular, Mo(2)(OAc)(4)-ind …
Social Deprivation and Post-TAVR Outcomes in Ontario, Canada: A Population-Based Study.
Patel RV, Ravindran M, Qiu F, Manoragavan R, Sud M, Tam DY, Madan M, Marcus G, Elbaz-Greener G, Mamas MA, Wijeysundera HC. Patel RV, et al. Among authors: qiu f. J Am Heart Assoc. 2023 Jan 3;12(1):e028144. doi: 10.1161/JAHA.122.028144. Epub 2022 Dec 24. J Am Heart Assoc. 2023. PMID: 36565194 Free PMC article.
Our co-primary outcomes were 1-year postprocedure mortality and 1-year postprocedure readmission. Using Cox proportional hazards models for mortality and cause-specific competing risk hazard models for readmission, we evaluated the relationship between neighborhood- …
Our co-primary outcomes were 1-year postprocedure mortality and 1-year postprocedure readmission. Using Cox proportional hazards mode …
Clinical Outcomes in Younger Women Hospitalized With an Acute Myocardial Infarction: A Contemporary Population-Level Analysis.
Madan M, Qiu F, Sud M, Graham MM, Saw J, Wijeysundera H, Kotrri G, Austin PC, Ko DT. Madan M, et al. Among authors: qiu f. Can J Cardiol. 2022 Nov;38(11):1651-1660. doi: 10.1016/j.cjca.2022.06.023. Epub 2022 Oct 5. Can J Cardiol. 2022. PMID: 36334935
We compared trends in comorbidities, angiographic findings, and revascularisation rates in men and women. The primary outcome was 1-year all-cause mortality or readmission for unstable angina, AMI, heart failure, or stroke. ...CONCLUSIONS: Coronary angiography is performed …
We compared trends in comorbidities, angiographic findings, and revascularisation rates in men and women. The primary outcome was 1-year all …
76 results